Cite
Design, synthesis and biological evaluation of novel triazoloquinazolinone and imidazoquinazolinone derivatives as allosteric inhibitors of SHP2 phosphatase.
MLA
Wenjun Ye, et al. “Design, Synthesis and Biological Evaluation of Novel Triazoloquinazolinone and Imidazoquinazolinone Derivatives as Allosteric Inhibitors of SHP2 Phosphatase.” Journal of Enzyme Inhibition & Medicinal Chemistry, vol. 37, no. 1, Dec. 2022, pp. 1495–513. EBSCOhost, https://doi.org/10.1080/14756366.2022.2078968.
APA
Wenjun Ye, Ye Liu, Qian Ren, Tianhui Liao, Yumei Chen, Dongmei Chen, Sisi Wang, Lihong Yao, Yihe Jia, Chunshen Zhao, & Zhixu Zhou. (2022). Design, synthesis and biological evaluation of novel triazoloquinazolinone and imidazoquinazolinone derivatives as allosteric inhibitors of SHP2 phosphatase. Journal of Enzyme Inhibition & Medicinal Chemistry, 37(1), 1495–1513. https://doi.org/10.1080/14756366.2022.2078968
Chicago
Wenjun Ye, Ye Liu, Qian Ren, Tianhui Liao, Yumei Chen, Dongmei Chen, Sisi Wang, et al. 2022. “Design, Synthesis and Biological Evaluation of Novel Triazoloquinazolinone and Imidazoquinazolinone Derivatives as Allosteric Inhibitors of SHP2 Phosphatase.” Journal of Enzyme Inhibition & Medicinal Chemistry 37 (1): 1495–1513. doi:10.1080/14756366.2022.2078968.